Table 3.
Percentage of detectable linearized HBsAg and HBcrAg after HBsAg seroclearance
| Time from HBsAg seroclearance (months) | Linearized HBsAg | HBcrAg | ||
|---|---|---|---|---|
| Detectable percentage (ratio) | p value | Detectable percentage (ratio) | p value | |
| a: 12 months | ||||
| ≤12 | 29.1% (52/179) | 0.146 | 24.6% (44/179) | 0.079 |
| >12 | 28.2% (33/150) | 20.0% (25/125) | ||
| b: 24 months | ||||
| ≤24 | 28.4% (71/250) | 0.076 | 20.0% (50/250) | 0.441 |
| >24 | 17.7% (14/79) | 24.1% (19/79) | ||
| c: 36 months | ||||
| ≤36 | 25.8% (73/283) | 0.901 | 20.1% (57/283) | 0.358 |
| >36 | 26.1% (12/46) | 26.1% (12/46) | ||
Patients were divided into two groups for analyses based on the time of measurement after HBsAg seroclearance as documented by a conventional HBsAg assay: 12 months (a), 24 months (b), and 36 months (c)
HBsAg hepatitis B surface antigen, HBcrAg hepatitis B core-related antigen